Page last updated: 2024-09-03

fosamprenavir and atomoxetine

fosamprenavir has been researched along with atomoxetine in 1 studies

Compound Research Comparison

Studies
(fosamprenavir)
Trials
(fosamprenavir)
Recent Studies (post-2010)
(fosamprenavir)
Studies
(atomoxetine)
Trials
(atomoxetine)
Recent Studies (post-2010) (atomoxetine)
174553741011

Protein Interaction Comparison

ProteinTaxonomyfosamprenavir (IC50)atomoxetine (IC50)
Cytochrome P450 2D6Homo sapiens (human)2
Prostaglandin G/H synthase 1Homo sapiens (human)3
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.0042
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)2
Type-1 angiotensin II receptorBos taurus (cattle)0.18
Sodium-dependent serotonin transporterHomo sapiens (human)0.1434
Sodium-dependent dopamine transporter Homo sapiens (human)3.0429
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)2.1

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1

Reviews

1 review(s) available for fosamprenavir and atomoxetine

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016